BPC-157 2mg — Body Protection Compound

BPC-157

Master peptide for tissue regeneration and repair

99% Purity Repair Neuroprotective

BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. It works as a systemic repair signal: it accelerates the healing of soft tissues, protects the digestive tract, and modulates inflammation without suppressing the immune system. Its core mechanism is the promotion of angiogenesis (the formation of new blood vessels) and the regulation of growth factors such as VEGF and nitric oxide.

Key Benefits

Accelerates healing of tendons and ligaments

Repairs gastric and intestinal mucosa

Reduces joint and muscle inflammation

Improves post-workout recovery

Protects against liver and vascular damage

Promotes connective-tissue regeneration

Mechanism of Action

Its core mechanism is the promotion of angiogenesis (the formation of new blood vessels) and the regulation of growth factors such as VEGF and nitric oxide, which accelerates soft-tissue healing and modulates inflammation without suppressing the immune system.

Verify Product Contact

Protocol

Reconstitution & Usage Protocol

Important: Only chill the water for 3 minutes before reconstituting the peptide. Do not prepare it with very cold water, because it may freeze, lose efficacy, or be damaged.

1Reconstitution

Materials: 1 vial of BPC-157 2 mg · 1 vial of bacteriostatic water · U-100 insulin syringe · alcohol wipes.

Bring the vial to room temperature by taking it out of the refrigerator 15–20 minutes beforehand.
Disinfect the rubber cap of both vials with an alcohol wipe. Let dry for 30 seconds.
Draw 2 mL of bacteriostatic water into a syringe (equivalent to 200 IU on an insulin syringe, or alternatively use a 3 mL syringe).
Inject the water slowly into the BPC-157 vial, directing the stream against the inner wall of the vial — never directly onto the powder.
Do not shake. Gently roll it between your palms or let it stand for 5–10 minutes until the solution turns clear.

Label the vial with the reconstitution date and store it in the refrigerator (2–8 °C). Stable for 28 days.

2Concentration & Dosing

Reconstituting 2 mg in 2 mL → 1 mg/mL = 10 mcg per IU.

Target dose	Units	Volume
100 mcg (low)	10 IU	0.10 mL
250 mcg (standard)	25 IU	0.25 mL
500 mcg (high)	50 IU	0.50 mL

Universal formula: IU = (dose in mcg ÷ 10)

3Application

Route

Subcutaneous in the abdomen (5 cm from the navel) or near the injured area for a local effect.

Frequency

Once a day, preferably on an empty stomach or before sleep.

Cycle

4–8 weeks, with a 2–4 week break between cycles.

Rotate the injection site with each application.
Before applying: let the drawn dose lose its chill (only the amount to be injected) — hold the syringe in your hand for 2–3 minutes.
After applying: gently massage the area for ~40 seconds to disperse the peptide and improve absorption.

Importante: Solo poner a enfriar el agua 3 minutos antes de reconstituir el péptido. No preparar con agua muy fría, porque se puede congelar, perder efecto o dañarse.

1Reconstitución

Materiales: 1 vial de BPC-157 2 mg · 1 vial de agua bacteriostática · jeringa de insulina U-100 · toallitas de alcohol.

Atemperar el vial sacándolo de la nevera 15–20 minutos antes.
Desinfectar la tapa de goma de ambos viales con toallita de alcohol. Dejar secar 30 segundos.
Cargar 2 mL de agua bacteriostática en una jeringa (equivale a 200 UI en jeringa de insulina, o bien usar una jeringa de 3 mL).
Inyectar el agua lentamente dentro del vial de BPC-157, dirigiendo el chorro hacia la pared interior del vial — nunca directamente sobre el polvo.
No agitar. Girar suavemente entre las palmas o dejar reposar 5–10 minutos hasta que la solución quede transparente.

Etiquetar el vial con la fecha de reconstitución y guardar en nevera (2–8 °C). Estable por 28 días.

2Concentración y dosis

Reconstituyendo 2 mg en 2 mL → 1 mg/mL = 10 mcg por UI.

Dosis objetivo	Unidades	Volumen
100 mcg (baja)	10 UI	0,10 mL
250 mcg (estándar)	25 UI	0,25 mL
500 mcg (alta)	50 UI	0,50 mL

Fórmula universal: UI = (dosis en mcg ÷ 10)

3Aplicación

Vía

Subcutánea en abdomen (a 5 cm del ombligo) o cerca de la zona lesionada para efecto local.

Frecuencia

1 vez al día, preferiblemente en ayunas o antes de dormir.

Ciclo

4–8 semanas, con descanso de 2–4 semanas entre ciclos.

Rotar sitio de inyección cada aplicación.
Antes de aplicar: dejar que la dosis cargada pierda el frío (solo la cantidad a inyectar) — sostener la jeringa en la mano 2–3 minutos.
Después de aplicar: masaje suave en la zona durante ~40 segundos para dispersar el péptido y mejorar absorción.

Important : Ne mettre l'eau à refroidir que 3 minutes avant de reconstituer le peptide. Ne pas préparer avec de l'eau très froide, car il peut geler, perdre son effet ou être endommagé.

1Reconstitution

Matériel : 1 flacon de BPC-157 2 mg · 1 flacon d'eau bactériostatique · seringue à insuline U-100 · lingettes d'alcool.

Tempérer le flacon en le sortant du réfrigérateur 15–20 minutes à l'avance.
Désinfecter le bouchon en caoutchouc des deux flacons avec une lingette d'alcool. Laisser sécher 30 secondes.
Prélever 2 mL d'eau bactériostatique dans une seringue (équivaut à 200 UI sur une seringue à insuline, ou bien utiliser une seringue de 3 mL).
Injecter l'eau lentement dans le flacon de BPC-157, en dirigeant le jet contre la paroi intérieure du flacon — jamais directement sur la poudre.
Ne pas agiter. Faire rouler doucement entre les paumes ou laisser reposer 5–10 minutes jusqu'à ce que la solution devienne transparente.

Étiqueter le flacon avec la date de reconstitution et conserver au réfrigérateur (2–8 °C). Stable pendant 28 jours.

2Concentration et dosage

En reconstituant 2 mg dans 2 mL → 1 mg/mL = 10 mcg par UI.

Dose cible	Unités	Volume
100 mcg (faible)	10 UI	0,10 mL
250 mcg (standard)	25 UI	0,25 mL
500 mcg (élevée)	50 UI	0,50 mL

Formule universelle : UI = (dose en mcg ÷ 10)

3Application

Voie

Sous-cutanée dans l'abdomen (à 5 cm du nombril) ou près de la zone lésée pour un effet local.

Fréquence

1 fois par jour, de préférence à jeun ou avant le coucher.

Cycle

4–8 semaines, avec une pause de 2–4 semaines entre les cycles.

Alterner le site d'injection à chaque application.
Avant l'application : laisser la dose prélevée perdre son froid (uniquement la quantité à injecter) — tenir la seringue dans la main 2–3 minutes.
Après l'application : masser doucement la zone pendant ~40 secondes pour disperser le peptide et améliorer l'absorption.

Open dosage calculator →

Research Highlights

Preclinical models report that BPC-157 promotes angiogenesis and upregulates VEGF signaling, supporting accelerated repair of tendons, ligaments, and muscle in tissue studies.
Gastrointestinal research highlights its protective effect on the gastric and intestinal mucosa, with study interest in models of gastritis, ulcers, and increased intestinal permeability.
Studies note a systemic anti-inflammatory profile alongside reported hepatic and vascular protection, modulating inflammation without suppressing the immune system.

FAQ

Frequently Asked Questions

What is BPC-157 and where is it derived from?

BPC-157 (Body Protection Compound) is a 15-amino-acid peptide derived from a protective protein found in human gastric juice. In research it is studied as a systemic repair signal, with reported effects on soft-tissue healing, gastrointestinal protection, and inflammation modulation. This material is supplied strictly for laboratory and research use.

What is BPC-157's main mechanism of action in research models?

Study models attribute its core activity to the promotion of angiogenesis — the formation of new blood vessels — alongside the regulation of growth factors such as VEGF and the nitric oxide pathway. This profile is associated with accelerated soft-tissue repair and with inflammation modulation that does not suppress the immune system. These descriptions reflect the literature and are not human-use claims.

How is BPC-157 reconstituted and what concentration does the 2 mg vial yield?

Reconstituting 2 mg in 2 mL of bacteriostatic water yields 1 mg/mL, which equals 10 mcg per IU on a U-100 insulin syringe. By the universal formula IU = (dose in mcg ÷ 10), a 100 mcg target equals 10 IU (0.10 mL), 250 mcg equals 25 IU (0.25 mL), and 500 mcg equals 50 IU (0.50 mL). Once reconstituted, label the vial and store it at 2–8 °C, where it is stable for 28 days.

What administration route and cycle are typical in BPC-157 research?

In documented protocols BPC-157 is administered subcutaneously — either in the abdomen, about 5 cm from the navel, or near the area of interest for a local effect — once daily, often on an empty stomach or before sleep. Typical study windows run 4–8 weeks followed by a 2–4 week break, with rotation of the injection site each application. These parameters describe research handling only and are not human-use instructions.

Related Compounds

← Previous

NAD+

TB-500 + BPC-157 Blend

← Back to full catalog